drugset / Trial / NCT00074477

Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia

NCT00074477

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the efficacy (how well the drug works), safety, and side effects of paliperidone palmitate injection compared to placebo in the treatment of the symptoms of schizophrenia in adults. The placebo used in this study was a nutritional substance known as 20% Intralipid emulsion given to patients requiring intravenous feedings.

Timeline

Start
2003-10
Primary completion
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject paliperidone palmitate Unknown 50 mg Intramuscular
Subject paliperidone palmitate Unknown 100 mg Intramuscular

Indications